Editorial comments: Episodes of penile erection, and the stretching and yawning syndrome can be induced in experimental animals by CNS administration of adrenocorticotropin and alpha-melanocyte-stimulating hormone. Prior studies have suggested that melanotropic peptides act downstream to the actions of dopamine and oxytocin. The authors evaluated the erectogenic properties of Melanotan-II, cyclic alpha-melanocyte-stimulating hormone analogue. A group of ten men with no known organic cause of their erectile dysfunction were entered into the study, and the effects of Melanotan-II (given subcutaneously in the abdomen) were compared to placebo using real-time Rigiscan monitoring over a six-hour period. The authors reported a statistically significant greater number of erectile events, duration of erectile activity, degree of rigidity and tumescence activity units in the drug group versus the placebo. The drug had no effects on sexual desire. The side-effect profile was also higher in the Melanotan-II group, including stretching and yawning, nausea, decreased appetite and changes in skin pigmentation.
This double-blind, crossover study is very signi®cant in that it represents the ®rst placebocontrolled investigation documenting the positive erectogenic effects of an alpha-MSH analogue in humans. Interestingly, the activity and toxicity of Melanotan-II are similar to another centrally-acting erectogenic agent, apomorphine, which also acts on the dopaminergic system. The side-effect pro®le of Melanotan-II was signi®cant and may represent a limiting factor in its usefulness for the treatment of erectile dysfunction. Further studies in larger groups of individuals, including men and women, possibly utilizing different routes of administration may help us to better understand the activity of these peptides and help de®ne their role in the management of sexual dysfunction. Editorial comments: The anatomic description of the female genital anatomy, both histologically and grossly, has traditionally been described in cursory or comparative terms. Accurate descriptions of the neurovascular supply to the perineal and genital area of the female are scant or absent in the current scientific literature. This important work describes accurately and in detail the gross anatomy of the urethra and its surrounding erectile tissue complex, clitoris, in the female. In order to determine the proper anatomic relationships, the perineum and pelvis of ten human female cadavers were dissected and documented photographically. The findings were then compared to the existing gross anatomy literature. Of note, a number of historic anatomic and descriptive inaccuracies were also documented and described. The complete anatomic description with photographs is presented in the article. The clinical importance of this study cannot be overstated. Since the early studies by Masters and Johnson, few investigations have scientifically investigated basic female sexual anatomy or physiology. Review of currently available surgical and anatomic atlases or comprehensive texts are severely deficient in these areas.
Recent demographic studies have revealed the high prevalence of female sexual dysfunction in our society, as well as its association with systemic and vascular risk factors and similarities to male erectile dysfunction. As we begin further investigations to better de®ne the underlying physiology and pathophysiology of female sexual dysfunction, detailed and accurate anatomic descriptions, such as the authors present here, will be critical in helping us not only to better understand the process, but to develop new and effective diagnostic and therapeutic modalities.
Buckling of cylinders may cause prolonged penile pain after prosthesis implantation: case control study using magnetic resonance imaging of penis I Moncada, C Hernandez, J Jara, L Hernandez et al
Madrid, Spain
J Urol 1998; 160: 67±71.
Editorial comments: A number of potential postoperative complications associated with penile implant surgery have been described, such as infection, erosion, perforation of cylinders, SST deformity and mechanical malfunction. Chronic penile pain, which persists beyond six weeks, is usually uncommon, and may be attributable to subclinical infection or other abnormalities. This study identified the risk factors associated with chronic postoperative penile pain after inflatable penile prosthesis insertion. Of the 65 patients in the study, 14 (21.5%) had chronic penile pain for more than two months without evidence of infection.
In order to visualize the position of the device components, in the de¯ated and in¯ated states, magnetic resonance imaging (MRI) was performed, as it has the capability of demonstrating penile anatomy in the orthogonal planes. The authors found that buckling of the de¯ated cylinders, within the corpora, on MRI was a strong predictor (300-fold increase versus absent of buckling) of noninfectious, prolonged pain. None of the other abnormal MRI ®ndings predicted persistent pain. In fact, when MRI ®ndings were compared to clinical data, the authors found that all patients presenting with pain had a pathological ®nding on MRI, representing 100% sensitivity and 92% speci®city. In patients who underwent subsequent surgery to correct the buckling cylinders, resolution of pain occurred in each case.
This important study re-emphasizes that proper sizing, and assurance that the rear ends of the cylinders reach the crural end of the corpus cavernosa, is of critical importance during implant surgery. The authors also point out that Mentor Corporation (Santa Barbara, CA) is now manufacturing a cylinder (the Alpha-1 narrow-base in¯atable penile prosthesis) which is speci®cally designed to facilitate crural insertion of the prosthesis within a ®brotic or narrowed corpus cavernosum.
LS Hakim, MD
Experience of treatment for congenital penile curvature K Nagao, A Yoshida, M Deguchi, K Suzuki, N Ishii, T Kawakami, K Ueda, K Nakajima, E Nozawa, H Hara, K Miura, N Ishii and M Shirai First Department of Urology, Toho University School of Medicine, Tokyo, Japan Impotence (Journal of the Japanese Society for Impotence Research) 1997; 13: 13±17. Abstract in English.
Editorial comment: The authors treated 12 patients with congenital penile curvature by a plication technique combined with the new shaving method. The patients' ages ranged from 18±56 y with a mean of 32.5 y. They underwent surgery under lumbar or local anesthesia. The new shaving method is as follows: multiple longitudinal incisions were made on the tunica albuginea without penetration and the suraface¯aps of tunica albuginea were excised with scissors. Then inverted plication was performed using 2-0 Nylon and bilateral reinforcement was done with 2-0 Vicryl. The postoperative observation period ranged from 3±28 months (mean 16.0 months). Results were satisfactory without recurrence or complications. We have to wait for the long term follow-up results but this new technique should be tried by urologists.
Y Kimoto, MD
Glucagon relaxes the isolated rabbit corpus cavernosum penis precontracted by noradrenaline DK Kim, K Furukawa and T Uchiyama Department of Pharmacology, Toho University School of Medicine, Tokyo, Japan Impotence (Journal of the Japanese Society for Impotence Research) 1998; 13: 1±8. English.
Editorial comment: Glucagon elevates the glucose level in blood. However, the relationship between plasma glucagon level and erectile dysfunction is not well understood. The authors investigated the effects of glucagon in isolated rabbit corpus cavernosum smooth muscle. Glucagon relaxed the noradrenaline-precontracted rabbit corpus cavernosum smooth muscle in a concentration-dependent manner. Neither atropine, nor L-NAME, nor propranolol affected the glucagon-induced relaxations. A phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX) signi®cantly potentiated the glucagon-induced relaxations. Consequently this glucagon-induced relaxation of rabbit corpus cavernosum smooth muscle is suggested to be mediated by the production of cyclic-AMP. This result may lead to new investigations in the ®eld of diabetesinduced erectile dysfunction.

Review of Impotence Literature
Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: A comparison with other species Burnett, AL, MD
S Cellik and S Moncada
The Cruciform Project, University College, London, United Kingdom, Proc. Natl. Acad. Sci. USA 1997; 94: 8226±8231.
Editorial comment: While recent studies have confirmed that nitric oxide (NO) is the principal inhibitory mediator of penile erection and basis for a nitrergic neurotransmission system in the penis, a new research direction has developed examining the interactions between this and alternative systems that influence erectile responses. These investigators have extended their earlier observations that excitatory noradrenergic contractions in rabbit anococcygeus muscle and corpus cavernosum only occur after but not during the period of electrical field stimulation (EFS) in organ bath studies except when the EFS period involves NO synthesis inhibition. On this basis, they contended that the nitrergic system not only modulates but fully controls noradrenergic sympathetic neurotransmission in erectile tissue. This investigation involved the evaluation of tissue responses with EFS in the presence and absence of noradrenaline and following pharmacological treatment regimens which targeted the prejunctional formation, nerve junctional action, and postjunctional effects of NO (as the latter effects pertain to cGMP signal transduction). Nitrergic control was observed in all treatment regimens which suggested the probable existence of a postjunctional physiological antagonism between NO and noradrenaline. The relatively enhanced nitrergic control observed in human and rabbit tissues as opposed to mouse and rat tissues suggested that the influence of the noradrenergic innervation in the latter two species may be greater than in the former two. Furthermore, the finding that the relatively increased tone of erectile tissue following histamine pharmacological stimulation can be further raised by inhibition of NO synthesis pointed to a basal release of NO in this tissue. These results provide some interesting insights into the coordination required of neurogenic factors in the penis and possible imbalances that may occur to explain different erectile dysfunction disease presentations. Additional work in this field may further clarify mechanisms that determine NO release at basal conditions and also its interactions with other mediators.
AL Burnett, MD
Sexual impotence is associated with a reduced production of oxytocin and with an increased production of opioid peptides in the paraventricular nucleus of male rats R Arletti, L Calza, L Giardino, A Benelli, E Cavazzuti and A Bertolini, Department of Biomedical Sciences, Section of Pharmacology, University of Modena and Pathophysiology Center for the Nervous System, Hesperia Hospital, Modena, Italy Neurosci Lett 1997; 233: 65±68.
Editorial comment: The importance of central nervous system effects on sexual function is gaining acceptance, with many previous reports proposing that different nervous structures in the brain affect male sexual behavior under the influence of a host of neurotransmitters and neuropeptides. These investigators have explored neurotransmitter contents in the paraventricular nucleus (PVN) of the hypothalamus in relationship to sexual function in male rats. Previously, they had shown that there is a reduced expression of nitric oxide (NO) synthase mRNA in this brain structure of sexually dysfunctional rats. In this investigation, quantification of in situ hybridization signals in the PVN of sexually dysfunctional rats, defined by abnormal sexual behavioral parameters, also showed a significant reduction of oxytocin mRNA expression and a significant increase of dynorphin and met-enkephalin mRNA expression compared with functionally normal rats; galanin mRNA expression was similar between groups. Also, serum measurements of corticosterone, testosterone and glucose were not significantly different between groups. These results coincide with previous experimental data indicating that oxytocin stimulates sexual activity, opioid neuropeptides inhibit this activity, and galanin exerts an equivocal role, all seemingly independent of endocrine effects. In all, the investigation further supports precepts that psychogenic erectile dysfunction conceivably derives from central biochemical disturbances. alternative pathways leading to erection may exist and substantially carry out this function in conditions of NO-deficiency. Furthermore, it may be contended that the androgenic influence on erectile function can also be exerted through mechanisms that do not involve NO. To examine these hypotheses, these investigators have evaluated erectile responses in a rat model of major pelvic ganglionic stimulation during NO synthase inhibition, with castration alone and after androgen replacement. Erections could be elicited but these were androgendependent, indicating the involvement of an alternative NO-independent pathway. The additional demonstration that androgen maintained erections, elicited during NO synthase inhibition, were augmented by phosphodiesterase 5 inhibition (which thereby facilitates cGMP effects) and attenuated by guanylate cyclase inhibition (which thereby hampers cGMP effects) suggested that this NOindependent pathway is mediated through a cGMP mechanism producing erectile tissue smooth muscle relaxation. This work furthers the contention that alternative neurotransmitter pathways exist to maintain erectile performance and hence may partly explain the retained erectile function in transgenic mice lacking the gene for neuronal NO synthase. The range of molecular targets that may have a role in erectile function is apparently diverse and suggests that continued efforts to explore these scientifically may yield alternative approaches to the pharmacological treatment of erectile dysfunction.
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